We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-6.73%
1 Year Est. Return
-12.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16M
AUM Growth
-$11.8M
Cap. Flow
-$21.9M
Cap. Flow %
-136.91%
Top 10 Hldgs %
86.36%
Holding
93
New
6
Increased
1
Reduced
3
Closed
19

Top Buys

Rank Stock Value
1
SHPH icon
Shuttle Pharmaceuticals
SHPH
+$308K
2
ATXG icon
Addentax Group
ATXG
+$266K
3
AUUD
Auddia
AUUD
+$121K
4
KSCP icon
Knightscope
KSCP
+$67.7K
5
ABTC
American Bitcoin Corp
ABTC
+$20.1K

Top Sells

Rank Stock Value
1
PMCB icon
PharmaCyte Biotech
PMCB
+$2.26M
2
LIBY
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
+$1.84M
3
VSAC
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
+$1.57M
4
FEXD
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
+$1.32M
5
AOGO
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.63%
2 Financials 11.39%
3 Real Estate 2.24%
4 Industrials 1.78%
5 Energy 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNVT
76
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
– –
-100,000
Closed -$1.04M
VSAC
77
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
– –
-150,000
Closed -$1.57M
AOGO
78
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
– –
-125,000
Closed -$1.3M
CLOEU
79
DELISTED
Clover Leaf Capital Corp. Unit
CLOEU
– –
-75,000
Closed -$6.75K
FEXD
80
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
– –
-125,000
Closed -$1.32M
LIBY
81
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
– –
-175,000
Closed -$1.84M
KVSA
82
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
– –
-101,732
Closed -$1.03M
GBRGR
83
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
– –
-134,500
Closed -$61K
MIMO.WS
84
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
– –
-150,000
Closed -$7.33K
CHEKZ
85
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
– –
-128,151
Closed -$1.4K
KALWW
86
DELISTED
Kalera Public Limited Company Warrant
KALWW
– –
-25,000
Closed -$673
BSGAR
87
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
– –
-70,000
Closed -$37.8K
1 2 3
4

Similar funds

VVA
Vintage Ventures Advisors Herzliya, Israel $15.2M AUM 35.41% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
TAM
Toscafund Asset Management London, United Kingdom $15.6M AUM 12.56% 1-Year Est. Return
RCGI
Ribbit Capital GP IV Palo Alto, California $15.6M AUM 103.62% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
CAM
Connacht Asset Management New York $16.9M AUM 40.41% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return

Ayrton Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Ayrton Capital held 93 positions worth $16M, down 42% from $27.9M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Ayrton Capital withdrew a net $21.9M in Q2 2023, closing 19 positions and reducing 3 holdings. Its most notable exit was Liberty Resources Acquisition Corp. Class A Common Stock, an estimated $1.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 17% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Ayrton Capital opened a new position in Shuttle Pharmaceuticals worth $289K.

  • Ayrton Capital's largest Q2 2023 buy was Shuttle Pharmaceuticals: 125 shares worth $289K.
  • Ayrton Capital added most to PAVmed in Q2 2023, an estimated $8.6K increase.
  • Ayrton Capital's biggest Q2 2023 reduction was PharmaCyte Biotech, cutting an estimated $2.26M.
  • Ayrton Capital fully exited Liberty Resources Acquisition Corp. Class A Common Stock in Q2 2023, selling an estimated $1.84M.
  • Ayrton Capital's ten largest holdings make up 86% of its $16M portfolio in Q2 2023.
  • Ayrton Capital opened 6 new positions and closed 19 in Q2 2023.
  • Ayrton Capital's portfolio value fell 42% quarter-over-quarter to $16M.

Based on Ayrton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.